The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia.
about
Proteomic and Microscopic Strategies towards the Analysis of the Cytoskeletal Networks in Major Neuropsychiatric DisordersGlobal quantitative analysis of phosphorylation underlying phencyclidine signaling and sensorimotor gating in the prefrontal cortex.Melatonin in Alzheimer's disease and other neurodegenerative disordersProof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophreniaA Tale of the Good and Bad: Remodeling of the Microtubule Network in the Brain by Cdk5Peptide neuroprotection through specific interaction with brain tubulinMyocardin-related transcription factors regulate the Cdk5/Pctaire1 kinase cascade to control neurite outgrowth, neuronal migration and brain developmentCellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disordersDifferential expression of cytoskeletal genes in the cochlear nucleus.New model of action for mood stabilizers: phosphoproteome from rat pre-frontal cortex synaptoneurosomal preparations.Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases.Understanding schizophrenia as a disorder of consciousness: biological correlates and translational implications from quantum theory perspectives.Impaired ILK Function Is Associated with Deficits in Hippocampal Based Memory and Synaptic Plasticity in a FASD Rat ModelA mouse model of term chorioamnionitis: unraveling causes of adverse neurological outcomesAltered Mitochondrial Dynamics Contributes to Propofol-induced Cell Death in Human Stem Cell-derived Neurons.Melatonin as a cytoskeletal modulator: implications for cell physiology and disease.Schizophrenia: an integrative approach to modelling a complex disorder.Neuroprotective effect of exogenous melatonin on dopaminergic neurons of the substantia nigra in ovariectomized rats.The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubulesA conceptual view at microtubule plus end dynamics in neuronal axons.Proteome analysis of schizophrenia brain tissue.Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampus.Increased Stability of Microtubules in Cultured Olfactory Neuroepithelial Cells from Individuals with Schizophrenia.Melatonin increases stress fibers and focal adhesions in MDCK cells: participation of Rho-associated kinase and protein kinase C.Potential Role of Microtubule Stabilizing Agents in Neurodevelopmental Disorders.Bilirubin as a determinant for altered neurogenesis, neuritogenesis, and synaptogenesis.Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission.Proteomics as a tool for understanding schizophrenia.Melatonin increases dendritogenesis in the hilus of hippocampal organotypic cultures.Neuroprotective actions of 2,4-dinitrophenol: Friend or foe?
P2860
Q26750966-59A8F422-2EAD-4028-84E3-56627A8D227AQ27319445-DFD1C9B1-A112-41C7-94B3-3B7FB2BED0A6Q28217483-E98E31CC-3628-42BD-ADA1-329E253A2569Q28240120-561A0027-ECD0-4F49-A177-A1566BACBB65Q28388637-4C3E47F0-3E23-49BF-ACE5-A6FE98684F49Q28573648-5CA971E7-D543-47F2-A872-98E7943393AAQ28585951-873590FE-A846-4CEC-BA01-3E90A2DDF1C8Q28754228-F2B3B1ED-BD42-422F-8CE8-260340799905Q30492995-92439184-B57A-48E4-BFEB-6B02C17AC9B4Q34729740-693B96AF-8C31-4A34-8E71-C011EAAB750FQ34986607-776E686A-A0CF-47B5-BA55-8D9CB48192F1Q35579200-B54ECE16-F8F9-443C-86DE-7AD19069E2AAQ35754558-A13C1B1C-2473-4190-9CAC-3440AFED682AQ35931046-E68E0E35-6CF7-4F49-86DC-F24BA02C5C17Q36248025-5258ECA1-741E-41AB-86CB-3EB8D9D2F832Q36325041-81684A8B-98B4-45F7-88B0-71536B147802Q36478249-8164B711-AA61-4121-B80A-006AF163E387Q36805092-AE324D83-54A3-4C89-91F2-3463678124C1Q36982616-256A9612-39FE-4BC6-A73C-A40D5E28A9B7Q37385728-BB251EC8-A3E5-46E7-8B05-EA0B394C9BF2Q37682924-5C0A8A56-C46E-42E0-B423-2056803DF3A5Q38022179-4C2F6F0E-BBB3-4DB1-B6D1-39267790A5F0Q38399332-4D40B0F2-0D8F-4DD7-8E68-F5F2C9B5A67CQ38960118-C53D677D-3ED4-40FB-848D-755A5F04FAA8Q40173626-11680CB7-AF20-4100-B71C-0D8B588BD6F3Q41573058-A21B9BD1-7861-4A35-A6CA-953FE62CAC70Q41848415-6EDC3048-BCB2-4D8F-8B61-BE2C9F8A422AQ42523654-1BA2EB31-5F78-4EF5-BF1E-0384387AB7EDQ43235632-EE5DDF06-72B2-4FB3-B746-570A0A107322Q46793814-BA14CB2B-423E-4366-AE96-B28DE2021A86Q47131459-BA992014-B0B6-48EA-B136-41ADE87AF71A
P2860
The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The neuronal cytoskeleton as a ...... ve diseases and schizophrenia.
@ast
The neuronal cytoskeleton as a ...... ve diseases and schizophrenia.
@en
type
label
The neuronal cytoskeleton as a ...... ve diseases and schizophrenia.
@ast
The neuronal cytoskeleton as a ...... ve diseases and schizophrenia.
@en
prefLabel
The neuronal cytoskeleton as a ...... ve diseases and schizophrenia.
@ast
The neuronal cytoskeleton as a ...... ve diseases and schizophrenia.
@en
P2093
P921
P356
P1476
The neuronal cytoskeleton as a ...... ve diseases and schizophrenia.
@en
P2093
Benitez-King G
Ramírez-Rodríguez G
P304
P356
10.2174/1568007043336761
P577
2004-12-01T00:00:00Z